Overview

Digoxin Drug-Drug Interaction With Lurasidone HCl

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the pharmacokinetic profile of digoxin when administered alone and when administered with repeated dose of lurasidone 120mg.
Phase:
Phase 1
Details
Lead Sponsor:
Sunovion
Treatments:
Digoxin
Lurasidone Hydrochloride